Diagnosis and Treatment of COVID-19: scoping review protocol

Authors

DOI:

https://doi.org/10.33448/rsd-v10i4.14068

Keywords:

Diagnosis; Pharmacological treatment; Management of drug therapy; Coronavirus infections; COVID-19; SARS-COV-2.

Abstract

This protocol is aimed at mapping publications related to diagnosis and treatment of COVID-19. It is a scoping review protocol that follows the method preconized by the Joanna Briggs Institute, other authors and the Guideline Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews. The PCC strategy (population, concept and context) did systematize the search that did be performed in the months of May and June of 2020, within PubMed, Cochrane, Embase, CINAHL, LILACS, SCOPUS and Web of Science databases. As for grey literature, Google Scholar will be used.  The results will be analyzed quantitatively and will be organized by themes and presented in terms of absolute and relative frequency. It is expected that this scoping review will contribute to the development of strategies for coping with the disease.

References

Abd El-Aziz, T. M. & Stockand, J. D. (2020). Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status. Infection, Genetics and Evolution, 83, 2-10. https://doi.org/10.1016/j.meegid.2020.104327

Arksey, H. & O’Malley, L. (2005). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology: Theory and Practice, [S. l.], 8(1), 19–32. https://doi.org/10.1080/1364557032000119616

Botero-Rodríguez, F, Franco, O. H & Gómez-Restrepo, C. (2020). Glosario para una pandemia: el ABC de los conceptos sobre el coronavirus. Biomédica. 40 (2): 12-26. https://doi.org/10.7705/biomedica.5605

Chilamakuri, R. & Agarwal, S. (2021). COVID-19: Characteristics and Therapeutics, Cells, 10(2):206. https://doi.org/10.3390/cells10020206

Coronavirus disease (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Palacios Cruz, M., Santos, E., Velázquez Cervantes, M. A. & León Juárez, M. (2020). COVID-19, una emergencia de salud pública mundial. Revista Clínica Española, 220:0-0. https://doi.org/10.1016/j.rce.2020.03.001

De Rose, D. U., Piersigilli, F., Ronchetti, M. P, Santisi, A., Bersani, I., Dotta, A., Danhaive, O. & Auriti, C. (2020). Novel Coronavirus disease (COVID-19) in newborns and infants: What we know so far. Italian Journal of Pediatrics, 45(56): 1-8. https://doi.org/10.1186/s13052-020-0820-x

Holshue, M. L. et al. (2020). First Case of 2019 Novel Coronavirus in the United States. The New England Journal of Medicine, 382(10): 929–936. https://doi.org/10.1056/nejmoa2001191

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y. & Lancet, L. Z (2020). Undefined. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 295(10223): 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5

JIN, Y. H. et al. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research BioMed Central., 7(4): 1-23. https://doi.org/10.1186/s40779-020-0233-6

Levac, D., Colquhoun, H. & O’brien, K. K. (2010) Scoping studies: Advancing the methodology. Implementation Science, 5(1): 1-9. https://doi.org/10.1186/1748-5908-5-69

LI, Q. et al. (2020). Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. New England Journal of Medicine, 382 (13): 1199–1207. https://doi.org/10.1056/NEJMoa2001316

Lu, H., Stratton, C. W. & Tang, Y. (2020). Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. Journal Medical Virology, 92(4): 401-02. https://doi.org/10.1002/jmv.25678

Peters, M. D. J., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., Mcinerney, P., Godfrey, C. M. & Khalil, H. (2020). Updated methodological guidance for the conduct of scoping reviews. JBI evidence synthesis, 18 (10): 2119–2126. https://doi.org/10.11124/JBIES-20-00167

Rothan, H. A. & Byrareddy, S. N (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Elsevier, 109: 1-4. https://doi.org/10.1016/j.jaut.2020.102433

Saha, R. P., Sharma, A. R., Singh, M. K., Samanta, S., Bhakta, S., Mandal, S., Bhattacharya, M., Lee S. S. & Chakraborty, C. (2020). Repurposing drugs, ongoing vaccine, and new therapeutic development initiatives against COVID-19. Pharmacol. 11(1258): 1-33. https://doi.org/10.3389/fphar.2020.01258

Samudrala, P. K., Kumar, P., Choudhary, K., Thakur, N., Wadekar, G. S., Dayaramani, R., Agrawal, M. & Alexander, A. (2020). Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. European.. Journal of Pharmacology, 883: 1-12. https://doi.org/10.1016/j.ejphar.2020.173375

Saul, S. & Einav, S.(2020). Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19. ACS Infect. Dis, 6: 2304–2318. https://doi.org/10.1021/acsinfecdis.0c00343

Hosseini, E. S., Kashani, N. R., Nikzad, H., Azadbakht, J., Bafrani, H. H. & Kashani, H. H. (2020). The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies. Virology, 551:1-9. https://doi.org/10.1016/j.virol.2020.08.011

Tricco, A. C. et al. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169&7): 467-473. https://doi.org/10.7326/M18-0850

WHO – World Health Organization. Coronavirus Disease (Covid-19): Vaccines. Status Of Covid-19 Vaccines Within Who Eul/Pq Evaluation Process. https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_16Feb2021.pdf

Zhang, W., Du, R., Li, B., Zheng, X., Yang, X., Hu, B., Wang, Y., Xiao, G., Yam, B., Shi, Z. & Zhou, P. (2020). Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect, 9(1): 386–389. https://doi.org/10.1080/22221751.2020.1729071

Downloads

Published

10/04/2021

How to Cite

BORTOLATO-MAJOR, C. .; COSTA, A. B. .; DALCOL , C. .; SEIVA, F. R. F. .; ALCANTARA, L. R. de S. .; CRUZ, C. F. R. .; MELO, E. C. . Diagnosis and Treatment of COVID-19: scoping review protocol. Research, Society and Development, [S. l.], v. 10, n. 4, p. e26010414068, 2021. DOI: 10.33448/rsd-v10i4.14068. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/14068. Acesso em: 25 nov. 2024.

Issue

Vol. 10 No. 4

Section

Health Sciences

License

Copyright (c) 2021 Carina Bortolato-Major; Aline Balandis Costa; Camila Dalcol ; Fábio Rodrigues Ferreira Seiva; Leia Regina de Souza Alcantara; Carolina Fordellone Rosa Cruz; Emiliana Cristina Melo

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.